Significance of risk polymorphisms for depression depends on stress exposure. by Gonda Xénia et al.
1SCIENTIFIC RepoRts |  (2018) 8:3946  | DOI:10.1038/s41598-018-22221-z
www.nature.com/scientificreports
Significance of risk polymorphisms 
for depression depends on stress 
exposure
Xenia Gonda  1,2,10, Gabor Hullam2,4, Peter Antal  4, Nora Eszlari2,10, Peter Petschner2,3, 
Tomas GM Hökfelt5, Ian Muir Anderson6,7, John Francis William Deakin  6,7,8,  
Gabriella Juhasz2,3,6,7,9 & Gyorgy Bagdy2,3,10
Depression is a polygenic and multifactorial disorder where environmental effects exert a significant 
impact, yet most genetic studies do not consider the effect of stressors which may be one reason 
for the lack of replicable results in candidate gene studies, GWAS and between human studies 
and animal models. Relevance of functional polymorphisms in seven candidate genes previously 
implicated in animal and human studies on a depression-related phenotype given various recent 
stress exposure levels was assessed with Bayesian relevance analysis in 1682 subjects. This Bayesian 
analysis indicated a gene-environment interaction whose significance was also tested with a 
traditional multivariate analysis using general linear models. The investigated genetic factors 
were only relevant in the moderate and/or high stress exposure groups. Rank order of genes was 
GALR2 > BDNF > P2RX7 > HTR1A > SLC6A4 > CB1 > HTR2A, with strong relevance for the first four. 
Robust gene-gene-environment interaction was found between BDNF and HTR1A. Gene-environment 
interaction effect was confirmed, namely no main effect of genes, but a significant modulatory effect 
on environment-induced development of depression were found. Our data support the strong causative 
role of the environment modified by genetic factors, similar to animal models. Gene-environment 
interactions point to epigenetic factors associated with risk SNPs. Galanin-2 receptor, BDNF and X-type 
purin-7 receptor could be drug targets for new antidepressants.
Animal models of depression usually imply environmental factors, such as chronic unpredictable stress or learned 
helplessness. After such exposures behavioural phenotypes related to depression (e.g., anhedonia) and anxiety 
(e.g., increased fear, inhibited locomotor activity to discover new environment) develop in rodents. These animal 
models are widely used to study biological pathways involved in depression, to discover new target proteins for 
new antidepressants, to test potential new antidepressant compounds and to find candidate genes for depression. 
In turn, candidate genes were usually selected from data of stressed animals1,2, and evidence has also accumulated 
that depressogenic effects of different stressors are mediated by different biological pathways3.
This approach sharply contrasts genome-wide association studies (GWAS), where several thousands of 
patients (cases) and controls are included without any knowledge of presence or type of previous stressors4. 
GWAS are the state-of-the-art approach to test genetic main effects, but not interaction effects. In GWAS can-
didate genes generally do not show evidence for association with depression5 which led several researchers to 
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question the candidate gene approach in general6,7. Furthermore, statistical power to detect interactions is typi-
cally less than for main effects8. In this study we selected seven candidate genes and used two completely different 
statistical approaches to test whether candidate gene approach has or has not relevance in a population with 
well-documented data on time and type of recent negative life events.
Family, twin, epidemiologic and molecular studies indicate that depression is a multifactorial illness showing 
a highly complex genetic architecture with a large number of loci, each contributing a very small effect size to 
the phenotype5. Heritability of depression depends on severity, estimated at approximately 37% in general pop-
ulation9, and 48–75% in hospital samples, the latter heritability of 75% shown in recurrent depression10. Specific 
gene variants have been difficult to identify11; positive findings in candidate gene studies have not been consist-
ently replicated and very few statistically robust risk loci have emerged from genome-wide association studies 
(GWAS)12, although one recent study using the extremely large cohort with less intensive phenotyping approach 
identified 15 loci in major depression (Hyde et al. 2016). In contrast, environmental factors such as recent stress-
ful life events and childhood trauma13 are associated with considerably greater risk of depression than specific 
genetic variants. Indeed, positive genetic studies of depression have emerged almost exclusively in interaction 
with adverse psychosocial exposures11,14.
As demonstrated by numerous studies the power to detect genetic influences may be increased by i) using 
“deep” or multiple related phenotypes, e.g. by considering a broader ‘multivariate’ phenotype than one categorical 
diagnosis15, ii) using risk groups, e.g. by separately analyzing those with marked exposure to psychosocial adver-
sity16, and iii) using pathways, e.g. by using enrichment methods for aggregating the effect of variants toward gene 
and pathway levels17. We have previously demonstrated these by showing that functionally related gene variants 
within a pathway from genomically diverse regions show similar GxE interactions with respect to a complex phe-
notype14,18. The applied Bayesian multivariate methods allow these 3 approaches to be combined; they blur the 
distinction between dependent and independent variables and instead evaluate the strength of all, or a predefined 
set of possible relationships across variables. Using these methods, we have reported convergence of functionally 
related genes within the signaling pathway of the neuropeptide galanin on a multivariate phenotype, including 
quantitative measure of anxiety and depression, which operated only in those exposed to environmental stress. 
The use of the broader multivariate phenotype including symptoms of depression and also anxiety after stressful 
events also parallels animal models like chronic unpredictable stress.
In the present study we investigated whether candidate genes from both animal models and human studies 
across different pathways implicated in depression also converge to show a strong main effect and/or influence 
risk in the context of environmental stress. We quantified and compared the Bayesian relevance of these genes 
in populations differently exposed to stressful recent negative life events and also sought gene-gene interaction 
effects. Thus we selected candidate genes a priori based on: i) evidence of role in depression in animal models 
and also in our previous human studies, ii) having functional polymorphisms if possible, and iii) directly or indi-
rectly influencing the main putative pathways of depression, including serotonin, HPA, neuropeptide, neurotro-
phin, endocannabinoid, and neuroinflammatory mechanisms. The following gene polymorphism were selected: 
rs6265 in BDNF18, rs8836 in GALR214, rs7766029 in CB119, rs6311 in HTR2A20, rs7958311 in P2RX721, rs6295 in 
HTR1A22 and 5-HTTLPR in SLCA416.
Results
The population was in Hardy-Weinberg equilibrium (p-value > 0.05). Description of the population is shown in 
Table 1. The three elements of the multiple phenotype showed strong correlations with each other confirming the 
relevance of the multiple depression related phenotype (Table S1).
Bayesian relevance analysis revealed that the investigated genetic factors were only relevant to the multiple 
depression-related phenotype in case of moderate or high RLE exposure (Fig. 1). In case of the low RLE exposure 
group all genetic factors were non-relevant with low posterior probabilities (pr <0.1). In this analysis relevance 
increases in parallel with posterior probability, and a strong relevance is associated with pr >0.5. Moderate and/
or high RLE exposure levels entailed an increased relevance of all SNPs compared to the low exposure case. For 
the investigated SNPs some were more relevant in the moderate, some others in the high RLE exposure groups. 
On one hand, SNPs rs6265 (BDNF) and rs8836 (GALR2) were strongly relevant with high posterior probabilities 
(pr = 0.74 and pr = 0.84 respectively) after moderate exposure. On the other hand, rs7958311 (P2RX7), rs6295 
(HTR1A) and 5-HTTLPR (SLC6A4) appeared more relevant in the high RLE exposure group. Among those the 
rs7958311 (P2RX7) SNP was the most relevant (pr = 0.62) followed by rs6295 (HTR1A) (pr = 0.59) and rs6265 
(BDNF) (pr = 0.57). Comparatively, 5-HTTLPR (SLC6A4), rs7766029 (CB1) and rs6311 (HTR2A) had relatively 
low posteriors even after moderate or high exposure, and can be considered less relevant in this multivariate 
model.
Two gene-gene interactions were found in the data (Fig. 2). A strong interaction between rs6265 (BDNF) and 
rs6295 (HTR1A) was revealed by both Bayesian relevance analysis and the GLM analysis of the models (Table 2). 
Another weak interaction between 5-HTTLPR (SLC6A4)-rs8836 (GALR2) was also suggested by Bayesian rel-
evance analysis, but was not confirmed by the GLM analysis. It is noteworthy that the P2RX7 polymorphism 
clearly stands alone, its effect is completely apart from any other SNPs included in the analysis, as shown on Fig. 2.
The Bayesian relevance analysis indicated a strong gene-environment interaction between the investigated 
genetic factors and RLE exposure. In order to confirm this interaction, a frequentist analysis involving GLM 
was performed using depression phenotypes as dependent variables, and age and gender as cofactors. Model-1 
served as the basis of comparison containing only RLE. Both Model-2 and Model-3 were compared to Model-
1, for further explanation see Fig. 3. Note that Model-1 was significantly different (due to RLE) from a null 
model consisting of only age and gender (p-value < 10−5). Model-2 containing only main effects of RLE and 
genetic factors is not significantly different (in terms of residual variance) from Model-1 containing only RLE 
(F = 1.55, p-value = 0.086). However, Model-3 including also the interaction between genetic factors and RLE is 
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significantly different compared to Model-1 (F = 1.887, p-value = 0.0016). In addition, an analysis of explained 
variance of the depression phenotype was also performed. Model-1 (relationship ‘a’, Fig. 3) explains 6.13% of 
variance, in contrast with a model containing only main effects of genetic factors corresponding to relationship 
‘b’ which explains 2.91% of variance. Model-2 (‘a’ + ‘b’), however, in terms of explained variance (7.03%) is not 
significantly different from Model-1 (Table 2). On the other hand, the interactions between RLE and genetic 
factors (relationship ‘c’, Fig. 3) explain a considerable amount of variance, making Model-3 (‘a’ + ‘b’ + ‘c’, 8.68%) 
significantly different from Model-1. Table 2 presents the comparison of the previously described three models all 
of which included age and sex as covariates.
In short, these results show that effects of investigated genetic factors can be decomposed to non-significant 
main effects and significant gene-environment interactions (Fig. 4).
A logistic regression analysis with age, gender and population as covariates indicated no main effects of the 
polymorphisms on depression (data not shown).
Finally, possible biases resulting from population differences and RLE exposure categories were investigated. 
A Bayesian analysis involving a population descriptor variable was carried out on the whole dataset as well on 
all RLE subpopulations. The analysis involving the whole dataset indicated no direct dependencies with respect 
to the population descriptor (pr <0.07), suggesting that there is no population stratification bias in this sam-
ple regarding the investigated SNPs. In case of the RLE subpopulations, inclusion of the population descriptor 
caused only minor differences (<0.15) in the relevance posteriors of genetic variables supporting stable genetic 
Demographics ALL BUD MAN
gender male (%) 509 (30.3%) 226 (33.7%) 283 (28%)
female (%) 1173 (69.7%) 445 (66.3%) 728 (72%)
age mean (SD) 33.23 (10.53) 31.78 (10.54) 34.2 (10.42)
lifetime depression (DEP) no (%) 958 (57%) 524 (78.1%) 434 (42.9%)
yes (%) 724 (43%) 147 (21.9%) 577 (57.1%)
recent negative life events (RLE)
low (%) 1134 (67.4%) 479 (71.8%) 651 (64.4%)
moderate (%) 311 (18.5%) 120 (18%) 191 (18.9%)
high (%) 237 (14.1%) 68 (10.2%) 169 (16.7%)
current depression score (BSI-DEP)
low (%) 1133 (67.4%) 543 (80.9%) 590 (58.4%)
moderate (%) 290 (17.2%) 92 (13.7%) 198 (19.6%)
severe (%) 259 (15.4%) 36 (5.4%) 223 (22.1%)
current anxiety score (BSI-ANX)
low (%) 1096 (65.2%) 503 (75%) 593 (58.7%)
moderate (%) 339 (20.2%) 122 (18.2%) 217 (21.5%)
severe (%) 247 (14.7%) 46 (6.9%) 201 (19.9%)
Genetic variables
5-HTTLPR ss (%) 307 (18.3%) 114 (17%) 193 (19.1%)
sl (%) 819 (48.7%) 328 (48.9%) 491 (48.6%)
ll (%) 556 (33.1%) 229 (34.1%) 327 (32.3%)
rs6265 (BDNF) GG (%) 1128 (67.1%) 442 (65.9%) 686 (67.9%)
AG (%) 484 (28.8%) 202 (30.1%) 282 (27.9%)
AA (%) 70 (4.2%) 27 (4%) 43 (4.3%)
rs6295 (HTR1A) GG (%) 425 (25.3%) 174 (25.9%) 251 (24.8%)
GC (%) 845 (50.2%) 366 (54.5%) 479 (47.4%)
CC (%) 412 (24.6%) 131 (19.5%) 281 (27.8%)
rs6311 (HTR2A) CC (%) 569 (33.8%) 224 (33.4%) 345 (34.1%)
CT (%) 832 (49.5%) 314 (46.8%) 518 (51.2%)
TT (%) 281 (16.7%) 133 (19.8%) 148 (14.6%)
rs7766029 (CB1) CC (%) 443 (26.3%) 164 (24.4%) 207 (20.5%)
CT (%) 868 (51.6%) 352 (52.5%) 516 (51%)
TT (%) 371 (22.1%) 155 (23.1%) 288 (28.5%)
rs7958311 (P2RX7) GG (%) 983 (58.4%) 422 (62.9%) 561 (55.5%)
AG (%) 610 (36.3%) 212 (31.6%) 398 (39.4%)
AA (%) 89 (6.3%) 37 (5.5%) 52 (5.1%)
rs8836 (GALR2) CC (%) 580 (34.5%) 216 (32.2%) 364 (36%)
CG (%) 820 (48.7%) 338 (50.4%) 482 (47.7%)
GG (%) 282 (16.8%) 117 (17.4%) 165 (16.3%)
Table 1. Population description. SD: standard deviation; BSI: Brief Symptom Inventory.
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effects (Supplementary Figure S1). Similarly, no direct dependencies between RLE and genetic variables were 
detected (pr <0.02), thus the gene-environment interaction with respect to depression phenotypes are not driven 
by direct RLE-gene associations. In addition, GLM models using also a continuous RLE variable were investi-
gated. The difference between the previously described Model-3 and the Model-1 remained significant (F = 1.567, 
p-value < 0.05) indicating a robust effect of RLE independently of scaling.
Discussion
Our study showed that the contribution of multiple previously identified risk functional polymorphisms of can-
didate genes mapping several important neurobiological pathways, implicated in depression and also showing 
stress-dependent effects in previous animal studies, was only manifested in persons exposed to at least moder-
ately to recent life events. They did not converge to show a detectable main effect, but together they significantly 
influenced the risk in the context of environmental stress. This was confirmed by Bayesian multivariate methods, 
namely, no relevance of any of the investigated risk variants was detected in persons with low exposure. For the 
moderately exposed population only the galanin-2 receptor and BDNF polymorphisms were relevant. The rank 
order of the genes was GALR2 > BDNF > P2RX7 > HTR1A > SLC6A4 > CB1 > HTR2A, with high relevance for 
the first four, among all exposure groups. Furthermore, 5-HTTLPR, the most extensively investigated polymor-
phism with respect to interaction with life events16,23,24 showed only very low relevance (Fig. 3). Since the func-
tional effect, in other words its effect on mRNA expression, of this genetic variant is the strongest among all of 
these on a molecular level, these data suggest that several other genes play a more prominent role in mediating the 
effects of recent stressors on depression. Our results also reflect that effect of risk variants may be activated differ-
entially depending on the level of exposure to stressors, and that the effects of differing severity of stress exposure 
may be mediated by partially different pathways and mechanisms.
Our study applied a multivariate depression-related phenotype incorporating lifetime depression, current 
depression, and anxiety to encompass various aspects of depression including also quantitative traits (e.g., depres-
sion and anxiety symptoms). This approach may have power advantage over diagnostic categories in epidemio-
logical, population genetic samples14,25,26. Defining phenotype is crucial in the case of depression which is a highly 
heterogeneous phenomenon27. There appears to be a significant overlap between depression and anxiety pheno-
types, expressed by the diagnostic category of anxious depression, and there is also high comorbidity between 
the two, with a significant impact on both the course and treatment of these disorders28. Besides both being 
stress-related disorders, there is also a significant proportion of shared genetic risk28, with several polymorphisms 
implicated in both depression and anxiety, arguing for a complex approach to this phenotype. Furthermore, the 
validity of self-report phenotype for major depression has been shown in a GWAS recently29. The phenotype 
including symptoms of depression and also anxiety after stressful events also parallels animal models like chronic 
unpredictable stress30,31. The independence of the used phenotypes would argue for their individual testing, but 
the strong and incomplete correlation among the elements also confirms the use of our multiple phenotype.
Another important novel aspect of our study is considering several functional polymorphisms previously 
described in human and animal studies from distinct pathways including the serotonergic and endocannabi-
noid systems, neuropeptides, neuroinflammation and neuroplasticity in one multivariate model. In our study we 
Figure 1. Relevance of genetic factors with respect to multiple depression-related phenotype in persons with 
low, moderate or high exposure to recent negative life events (RLE). Possible dependency relationship models 
of genetic variables were investigated for each RLE subgroup. Then, relying on Bayesian model averaging 
an individual posterior probability score was computed for each genetic factor. Results indicate that these 
genetic factors are relevant to depression only in subjects with moderate or severe RLE exposure. In addition, 
several factors such as BDNF, GAL-R2, HTR1A, and P2RX7 appear more relevant with respect to depression 
in moderate and severe RLE subgroups than the highly investigated serotonin transporter related 5-HTTLPR. 
Posterior probabilities of >0.50 indicate strong relevance and are marked with bold numbers.
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targeted depression as a complex disease and a product of multiple networks, where the activity of the pathways 
may be shaped by environmental experience32, which was quantified in each person.
Compared to heritability which accounts for 37–42% in the variance in general population samples9, influence 
of environmental effects is estimated at 63% in depression28. Etiologically relevant distal and proximal stressors 
are relatively common, and while frequency of severe life events is estimated to be one in every 3–4 years, depres-
sion is triggered in only about one fifth of those with acute stress exposure33. There is a pronounced individual 
variation in the sensitivity towards environmental exposure at least in part due to genetic factors, and several 
Figure 2. Statistical interactions between genetic factors with respect to multiple depression-related 
phenotypes in persons with high exposure to recent negative life events. A Bayesian interaction score was 
computed for all possible variable pairs in order to measure their joint occurrence in relevant models with 
respect to multiple depression-related phenotypes. The individual relevance of each SNP is shown in the outer 
grey ring with red columns having a height proportional to their relevance. Possible interactions between 
SNPs are represented by curved red lines between corresponding columns with a width proportional to the 
likeliness of the interaction. Interactions related to SNPs with low individual relevance (e.g. CB1 and HTR2A 
SNPs, denoted with dashed orange lines) can be neglected, as the interaction score is sufficient only in case of 
variables with moderate or high relevance. Results indicated two interactions: a strong interaction between 
rs6265 (BDNF) - rs6295 (HTR1A) and a mild interaction between 5-HTTLPR (SLC6A4) – rs8836 (GALR2). The 
rs6265 (BDNF) - rs6295 (HTR1A) interaction was also observed in the GLM analysis of models (see Table 2). 
In contrast, the interaction of 5-HTTLPR (SLC6A4) – rs8836 (GALR2) was not revealed by the GLM analysis, 
which indicates that this interaction is of a different type, and only detectable by systems-based methods. Note 
that results shown in Fig. 1 suggest that the 5-HTTLPR (SLC6A4) and rs8836 (GALR2) SNPs have separate main 
effects with respect to depression.
Compared Models DF-1 DF-2 F p-value Variance explained
Model 1 (‘a’)
RLE
Model 2 (‘a’ + ‘b’)
RLE + genetic factors
(only main effects)
4 18 1.55 0.086 Model 16.13%
Model 2
7.03%
Model 1(‘a’)
RLE
Model 3 (‘a’ + ‘b’ + ‘c’)
RLE + genetic factors
(main effects + interactions)
4 38 1.88 0.002 Model 16.13%
Model 2
8.68%
Table 2. Comparison of GLM models indicating the importance of gene-environment interactions. Three 
GLM models were constructed (see Fig. 1 for an illustration of included dependency relationships): (1) Model-1 
containing only main effect of the environmental factor (relationship ‘a’), and (2) Model-2 containing only 
main effects of the environmental and genetic factors (‘a’ + ‘b’), and (3) Model-3 containing main effects plus 
interactions of the environmental and genetic factors (‘a’ + ‘b’ + ‘c’). Note that the inclusion of gene-environment 
interaction in Model-3 provides a significantly better model compared to Model-2 containing only main 
effects. DF-1 and DF-2 represents degrees of freedom for compared models, and F represents the value of the 
corresponding F statistic.
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genes are not directly involved in the development of depression but via influencing vulnerability towards effects 
of environmental stressors10,12.
The relationship between environmental and genetic influences is manifold. The effect of genetic and envi-
ronmental factors may be additive, or genetic variants may increase the likelihood of subjects seeking risk envi-
ronments or life events causing gene-environment correlation as shown by twin and adoption studies34–36. The 
exact nature of the interaction between genes and environment (GxE) is controversial. While the diathesis-stress 
model37 proposes that vulnerability towards environmental triggers depends on the biological background, 
including the genotype, which buffers or exacerbates the effect of stressors, the differential susceptibility model38 
incorporates a possible positive environmental aspect5, postulating that the biological context modulates the sen-
sitivity to both positive and negative environmental influences, making individuals not vulnerable, but ‘plastic’, in 
their response to the environment39.
Lack of consideration of such environmental effects may be one prominent reason for the failure of replica-
tion in candidate gene studies and GWAS into the genetic background of depression25,40. The only GWAS where 
additional genome-wide by environment interaction study (GWEIS) was also performed included population 
data from African American and Hispanic/Latina women25. Despite the fact that the population was markedly 
different from ours, including ethnicity, gender, age, prevalence of negative life events and stress exposure, there 
are important conclusions from that study. No genome-wide significant main effect was found in the GWAS, but 
a significant GWEIS hit was described in the African American sample. Furthermore, depressive symptoms and 
stressful life events were strongly genetically correlated25. Interaction of polygenic risk scores with environmental 
effects has been investigated in a similarly small number of studies, with negative results for interaction with 
recent life events11,13.
Our results throw light on a further important aspect of GxE in the development of depression, that is, 
whether environmental factors play a permissive role modulating the manifestation of genetically-based pheno-
types or a causative role, with genetic factors only modifying this effect. It has already been proposed that genes 
act by modifying vulnerability towards environmental influences rather than directly playing a causative role in 
Figure 3. Illustration of dependency relationships included in GLM models investigating the role of genetic 
and environmental factors with respect to depression phenotypes. Relationships ‘a’ recent life events (RLE) 
and ‘b’ represent the main effect of genetic factors, respectively, on depression phenotypes. Relationship ‘c’ 
represents the interaction between genetic factors and RLE. Model 1: effect of ‘a’. Model 2: effect of ‘a + b’. Model 
3: effect of ‘a + b + c’.
Figure 4. The role of all investigated candidate genes reveals in gene-environment interactions instead 
of main effects in the development of depression. Results of this study indicate that the polymorphisms 
of the investigated candidate genes have negligible main effects on depression. Instead, the interactions of 
these genetic variables in interaction with environmental factors, such as exposure to stress influence the 
development of depression.
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the development of depression10,12. This may be even more evident in our candidate gene selection, as animal 
models of depression usually depend on stress-induced depression-like behaviour. The larger increase in depres-
sion risk due to an interaction between genetic effects and life events than expected by combining their individual 
effects (Fig. 3 and Table 2) is an important argument against the first assumption, see also11,14, and thus, our 
results suggest that risk genetic variants may show differential activation as a function of evironmental exposure. 
Furthermore, effects caused by different severity of exposure may be mediated by partially different pathways. 
These data indicate a causative role for the environment, only modified by the genetic factors studied here. In 
other words, our results show that genes described here do not have a weak main effect, but rather a detectable 
modulatory effect.
Our study has several limitations. Our multiple depression-related phenotype and recent life events were 
measured based on self-report and these are subject to recall and reporting bias, although we applied only vali-
dated instruments and validated our phenotype in a subsample, furthermore the validity of self-report phenotype 
for major depression has been validated also in a GWAS recently. In addition, lifetime depression (also included 
in our multiple phenotype) was not controlled for timing of recent life events. Furthermore, this is a hypothesis 
driven candidate gene study which assessed a limited number of genetic variants (functional polymorphisms in 
seven candidate genes previously implicated in animal and human depression studies) on a moderately large sam-
ple. Therefore, results can be potentially inflated, and an independent study is required in the future to validate 
these results preferably using imputed GWAS data. That would allow the investigation of the contributions of all 
genes in the genome in the context of environmental stressors. The application of Bayesian systems-based meth-
ods would be advantageous in such a scenario as well, as they are better powered to uncover modest interaction 
effectsthan non-Bayesian methods using correction against multiple hypothesis testing. However, the computa-
tional scaling of systems-based methods to a genome-wide level still requires further research.
With these limitations in mind, our results suggest a potential role of the candidate gene-environment inter-
action. They indicate a complex interaction pattern between candidate genetic variants in different neurobio-
logical pathways and severity of exposure to life events in the emergence of depression. Neither the separate, 
nor the combined effect of the investigated polymorphisms was detectable on depression in the absence of stress 
exposure. In contrast, several genes modulated the effects of recent stressors, and their effects converged to a 
significant modulation on the development of depression. Furthermore, different levels of stress exposure were 
modulated differently by distinct genes reflecting multiple mechanisms underlying the effects of different severity 
of life events in the development of depression. Given the near complete lack of effect of our studied polymor-
phisms in the absence of at least moderate exposure to recent stressors, it is obvious that effects of important 
genetic variants are overlooked in samples, if the presence of stressors has not been considered in depression. 
Also, it is possible that different pathways play a role in the development of depression depending on whether life 
events are present or not; and different types or even severity of life events may be modulated by different neural 
mechanisms and pathways. These data emphasize the need for incorporating environmental variables in GWAS.
Methods and Materials
Study population. The study was part of the EU-funded NewMood study (New Molecules in Mood 
Disorders, Sixth Framework Program of the EU, LSHM-CT-2004-503474) approved by local Ethics Committees 
(North Manchester Local Research Ethics Committee, Manchester, UK; Scientific and Research Ethics Committee 
of the Medical Research Council, Budapest, Hungary), and carried out in accordance with the Declaration of 
Helsinki and all relevant guidelines and regulations. Before participating, all subjects provided written informed 
consent.
Description of the population and questionnaires have been published previously14,18,19. In this cur-
rent study we investigated how genetic variants of candidate genes interact with life-stressors on a multi-
ple depression-related phenotype in a European population cohort of 1682 subjects which is a subset of the 
NewMood study population consisting of subjects that were successfully genotyped with respect to all seven 
investigated genetic factors and had available data for all parameters included in this analysis. Recent negative life 
events (RLE), lifetime depression, Brief Symptom Inventory (BSI) depression and anxiety scores were determined 
in each subject. Relevant population data are provided in Table 1.
Phenotype. In the present study, we analyzed reported lifetime depression, current depression and anxi-
ety jointly as a multiple depression-related phenotype described previously14,24. Reported lifetime depression 
(DEP) was determined using the background questionnaire. Subsequently, the Structured Clinical Interview 
for DSM-IV (SCID) was used to validate findings18. Current depressive symptoms were measured based on the 
depression items plus the additional items (BSI-DEP), and anxiety using the anxiety items (BSI-ANX) of the 
BSI41. A weighted score was computed separately for BSI-DEP and BSI-ANX variables by summing the corre-
sponding item scores divided by the number of items completed and categorized into low (0 − < 1), moderate (1 
− < 2), and severe (2–4) categories.
In order to identify recent negative life events (RLE) we used the List of Threatening Experiences question-
naire42 which queried problems related to illnesses/injuries, financial difficulties, problems related to intimate 
relationships, and social network occurring in the last year. Based on corresponding items the number of RLEs 
was counted for each subject, and categorized (low = 0–1, moderate = 2, high = 3/more) as used in our previous 
studies19. The resulting low, moderate and high RLE exposure groups were used in the statistical analysis.
Genotyping. We genotyped seven a priori selected polymorphisms (rs6265, rs8836, rs7766029, rs6311, 
rs7958311, rs6295 and 5-HTTLPR) based on evidence from previous studies on involvement in depression. 
Buccal mucosa cells were collected for genotyping using a cytology brush (Cytobrush plus C0012, Durbin PLC, 
Harrow UK) and 2.0 mL collection buffer in 15-mL plastic tubes. Genomic DNA was extracted according to a 
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previously published protocol43. Laboratory work was carried out according to the ISO 9001:2000 quality man-
agement requirements and was blinded with regard to phenotype.
Statistical methods. In order to efficiently explore relevant factors and interactions for complex pheno-
types represented by multiple variables, we applied the Bayesian network based Bayesian multi-level analysis of 
relevance BN-BMLA (Antal et al., 2008), which is referred to as Bayesian relevance analysis in the paper. This 
method utilizes special hierarchical structural properties of Bayesian networks representing essential concepts 
in relevance analysis such as Markov blanket memberships, Markov blanket sets, and Markov blanket graphs. 
Bayesian relevance analysis applies a Markov Chain Monte Carlo sampling method to perform a random walk in 
the space of directed acyclic graphs44. This MCMC process results in samples of DAG structures which are used 
to estimate the consistent posteriors for structural properties representing relevance, e.g. posteriors for Markov 
blanket memberships representing strong relevance45. Thus this method quantifies the relevance of variables with 
respect to one or more selected target variables as probability scores (posterior probability of strong relevance) 
relying on Bayesian model averaging46.
In this study, all genetic factors were analyzed jointly in a multivariate model14,24, specifically we aimed to 
investigate the relevant relationships concerning the depression related complex phenotype described by three 
variables (DEP, BSI-DEP, BSI-ANX) and possible statistical interactions with recent negative life events. The 
Markov blanket graphs representing these relations are the hypotheses in our approach, which takes into account 
the potential interdependencies of the target variables. Because the Bayesian approach induces a posterior distri-
bution over this hypothesis space, it provides an efficient handling of multiple hypothesis testing.
The Bayesian relevance analysis was configured and executed to estimate Markov blanket membership pos-
terior probabilities using a uniform structure prior, a Cooper-Herskovits parameter prior47 with 106 burn-in and 
5 × 106 normal steps. In addition, the maximum number of parents (i.e. number of incoming edges) was limited 
to 5. The parameter prior was non-informative with respect to the data set, and it was selected based on our pre-
vious experiments with parameter priors48. Analyses were carried out for each RLE exposure group separately. 
Age and gender was included in each multivariate model. Note that the multivariate model provided by Bayesian 
relevance analysis allows the investigation of interactions on a system level, which is in line with recent recom-
mendations regarding GxE analyses7.
In addition, a frequentist multivariate analysis using general linear models (GLM) was applied to test the 
significance of the interaction of the investigated genetic factors and recent negative life events versus the effect 
of recent negative life events on the multiple depression-related phenotype. Three GLM models were constructed 
(Fig. 3, Table 2) for an illustration of included dependency relationships): (1) Model-1 containing only main effect 
of the environmental factor (relationship ‘a’), and (2) Model-2 containing only main effects of the environmental 
and genetic factors (‘a’ + ‘b’), and (3) Model-3 containing main effects of the environmental and genetic factors 
(see Model-2) plus interactions of environmental and genetic factors (‘a’ + ‘b’ + ‘c’). Age and gender were included 
as cofactors in all models. The residual variance of the models was compared and tested using an F-statistic. GLM 
analyses were performed with SPSS21.0 for Windows (IBM, Armonk, NY) using a significance threshold 0.05.
Data availability. The datasets generated and analysed during the current study are available in the Figshare 
repository, https://figshare.com/s/737f45fe41522e601d0a.
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